+163.8%
MPC vs EMR
+85.7%
+78.1%
-44.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -0.2% | -1.1% | -1.2% |
| 7D | -16.2% | -1.6% | -14.6% | -15.9% |
| 30D | -15.7% | +2.0% | -17.7% | -16.4% |
| 3M | +24.9% | +3.8% | +21.1% | +23.0% |
| 6M | +52.7% | +10.5% | +42.1% | +46.4% |
| YTD | +131.9% | +23.7% | +108.1% | +108.1% |
| 1Y | +96.6% | +25.4% | +71.2% | +74.9% |
| 3Y | +163.8% | +86.6% | +77.2% | +91.5% |
| All | +163.8% | +85.7% | +78.1% | +91.5% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling